Incidence of AIDS-Defining Conditions Among Adults With Perinatally Acquired HIV After Transition to Adult HIV Care in the United States and Canada, 2000-2022
- PMID: 40469005
- PMCID: PMC12375960
- DOI: 10.1093/cid/ciaf300
Incidence of AIDS-Defining Conditions Among Adults With Perinatally Acquired HIV After Transition to Adult HIV Care in the United States and Canada, 2000-2022
Abstract
Background: Little is known about the incidence of AIDS-defining conditions (ADCs) among people with perinatally acquired human immunodeficiency virus (PHIV) who transitioned to adult human immunodeficiency virus (HIV) care in the United States and Canada. We described the incidence among PHIV and compared it with that among those with non-perinatally acquired HIV (non-PHIV) and across calendar era.
Methods: Using data from the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) from 2000-2022, we estimated weighted mean cumulative counts (MCCs) of ADCs, comparing people with PHIV and non-PHIV acquisition risk groups aged 18-40 years engaged in adult HIV care. The weights accounted for differences in characteristics among HIV acquisition risk groups as well as informative censoring. We calculated 95% confidence intervals using bootstrapping. We stratified results before and after 2012, when the immediate start of antiretroviral therapy was first recommended.
Results: There were 5429 ADCs among 22 950 people with HIV. Among those with PHIV, the MCC of ADCs by 3 years in adult HIV care was 26 per 100 persons (95% confidence interval, 15-40) in 2000-2011 and 16 per 100 (5-21) in 2012-2022. Within each calendar era, weighted MCCs of ADCs among people with PHIV were similar or lower than in non-PHIV groups. Within each HIV acquisition risk group, weighted MCCs of ADCs were lower in 2000-2011 than in 2012-2022.
Conclusions: People with PHIV who transitioned to adult HIV care did not experience a greater ADC incidence than those with non-PHIV. This emphasizes the importance of continued engagement in adult HIV care, as it provides critical opportunities for ADC prevention and management.
Keywords: AIDS-defining conditions; HIV; lifetime survivors; perinatally acquired.
© The Author(s) 2025. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Conflict of interest statement
Potential conflicts of interest. C. R. L., D. K. N., T. R. S., J. L., A. A., and K. A. have received research grants from the NIH to their respective institutions. K. G. has received royalties from UpToDate; has served on a scientific advisory board for Shionogi and Pfizer (noncompensated); has received personal consulting fees from Spark HealthCare, Premier HealthCare, Harrison Consulting, and MedEd Learning; and has served on scientific advisory boards of Shionogi and Pfizer. A. A. has previously served on the scientific advisory boards of Gilead and Merck and as a site investigator under a clinical research contract with Gilead managed through Johns Hopkins University. K. A. has received royalties from Coursera. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Figures
References
MeSH terms
Grants and funding
- K23 EY013707/EY/NEI NIH HHS/United States
- R01 AI177010/AI/NIAID NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- U01 HL146192/HL/NHLBI NIH HHS/United States
- U01 AI069432/AI/NIAID NIH HHS/United States
- K01 AI131895/AI/NIAID NIH HHS/United States
- R01 AA016893/AA/NIAAA NIH HHS/United States
- U01 DA036297/DA/NIDA NIH HHS/United States
- U01 HL146241/HL/NHLBI NIH HHS/United States
- Grady Health System
- P30 AI050409/AI/NIAID NIH HHS/United States
- U01 HL146333/HL/NHLBI NIH HHS/United States
- F31 AI124794/AI/NIAID NIH HHS/United States
- P30 MH062246/MH/NIMH NIH HHS/United States
- U01 AI069434/AI/NIAID NIH HHS/United States
- National Institute for Mental Health
- R01 DA011602/DA/NIDA NIH HHS/United States
- DC/NIDCD NIH HHS/United States
- Government of Alberta
- Z01 CP010176/ImNIH/Intramural NIH HHS/United States
- NR/NINR NIH HHS/United States
- U54 GM133807/GM/NIGMS NIH HHS/United States
- National Institute of Allergy and Infectious Diseases
- P30 AI094189/AI/NIAID NIH HHS/United States
- U01 HL146245/HL/NHLBI NIH HHS/United States
- Eunice Kennedy Shriver National Institute of Child Health & Human Development
- G12 MD007583/MD/NIMHD NIH HHS/United States
- K24 DA000432/DA/NIDA NIH HHS/United States
- U01 HL146205/HL/NHLBI NIH HHS/United States
- U01 DA036935/DA/NIDA NIH HHS/United States
- 90047713/HS/AHRQ HHS/United States
- U01 AI038855/AI/NIAID NIH HHS/United States
- U01 HL146208/HL/NHLBI NIH HHS/United States
- TGF-96118/CAPMC/ CIHR/Canada
- Ontario Ministry of Health and Long Term Care
- K01 AI157849/AI/NIAID NIH HHS/United States
- R24 AI067039/AI/NIAID NIH HHS/United States
- U01 HL146242/HL/NHLBI NIH HHS/United States
- 90051652/HRSA/HRSA HHS/United States
- U10 EY008057/EY/NEI NIH HHS/United States
- U01 AI068636/AI/NIAID NIH HHS/United States
- U01 AI038858/AI/NIAID NIH HHS/United States
- CBR-86906/CAPMC/ CIHR/Canada
- U01 HL146201/HL/NHLBI NIH HHS/United States
- NS/NINDS NIH HHS/United States
- U01 HL146193/HL/NHLBI NIH HHS/United States
- U10 EY008052/EY/NEI NIH HHS/United States
- U01 AA020790/AA/NIAAA NIH HHS/United States
- HG/NHGRI NIH HHS/United States
- UL1 TR002378/TR/NCATS NIH HHS/United States
- R34 DA045592/DA/NIDA NIH HHS/United States
- P30 AI027763/AI/NIAID NIH HHS/United States
- U01 AI069918/AI/NIAID NIH HHS/United States
- K24 AI118591/AI/NIAID NIH HHS/United States
- K01 AI093197/AI/NIAID NIH HHS/United States
- U01AI069918, F31AI124794, F31DA037788, G12MD007583, K01AI093197, K01AI131895, K01AI157849, K23EY013707, K24AI065298, K24AI118591, K24DA000432, KL2TR000421, N01CP01004, N02CP055504, N02CP91027, P30AI027757, P30AI027763, P30AI027767, P30AI036219, P30AI050409, P30AI050410, P30AI094189, P30AI110527, P30MH62246, R01AA016893, R01AG053100, R01AI177010, R01DA011602, R01DA012568, R24AI067039, R34DA045592, U01AA013566, U01AA020790, U01AI038855, U01AI038858, U01AI068634, U01AI068636, U01AI069432, U01AI069434, U01DA036297, U01DA036935, U10EY008057, U10EY008052, U10EY008067, U01HL146192, U01HL146193, U01HL146194, U01HL146201, U01HL146202, U01HL146203, U01HL146204, U01HL146205, U01HL146208, U01HL146240, U01HL146241, U01HL146242, U01HL146245, U01HL146333, U24AA020794, U54GM133807, UL1RR024131, UL1TR000004, UL1TR000083, UL1TR002378, Z01CP010214, and Z01CP010176/NH/NIH HHS/United States
- K24 AI065298/AI/NIAID NIH HHS/United States
- U01 AA013566/AA/NIAAA NIH HHS/United States
- N02 CP055504/CP/NCI NIH HHS/United States
- CDC-200-2015-63931/CC/CDC HHS/United States
- UL1 TR000083/TR/NCATS NIH HHS/United States
- P30 AI027757/AI/NIAID NIH HHS/United States
- U01 HL146204/HL/NHLBI NIH HHS/United States
- National Institute of Dental & Craniofacial Research
- R01 DA012568/DA/NIDA NIH HHS/United States
- U01 HL146202/HL/NHLBI NIH HHS/United States
- CDC-200-2006-18797/CC/CDC HHS/United States
- CBR-94036/CAPMC/ CIHR/Canada
- KL2 TR000421/TR/NCATS NIH HHS/United States
- CC999999/ImCDC/Intramural CDC HHS/United States
- UL1 TR000004/TR/NCATS NIH HHS/United States
- U01 HL146240/HL/NHLBI NIH HHS/United States
- DK/NIDDK NIH HHS/United States
- F31 DA037788/DA/NIDA NIH HHS/United States
- R01 AG053100/AG/NIA NIH HHS/United States
- U10 EY008067/EY/NEI NIH HHS/United States
- P30 AI036219/AI/NIAID NIH HHS/United States
- U01 HL146194/HL/NHLBI NIH HHS/United States
- U24 AA020794/AA/NIAAA NIH HHS/United States
- HCP-97105/CAPMC/ CIHR/Canada
- U01 HL146203/HL/NHLBI NIH HHS/United States
- U01 AI068634/AI/NIAID NIH HHS/United States
- P30 AI050410/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
